Document Detail


Erythropoietin and retinopathy of prematurity.
MedLine Citation:
PMID:  21303729     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Erythropoietin (EPO) is a glycoprotein that regulates many functions of an organism: It stimulates the production of red blood cells and it has angiogenic and neuroprotective properties in newborn infants. Retinopathy of prematurity (ROP) is a frequent cause of visual impairment in preterm newborn infants and it has two distinct phases in which hypoxia-induced angiogenic factors are involved. The relationship between EPO and ROP is derived from the observation of studies done on the haematopoietic effect of EPO. The first observations suggested that a precocious treatment with EPO increases the risk of ROP, while the most recent reports suggested that the late treatment with high doses of rhEPO can increase the risk of ROP. All these studies were not designed to demonstrate the relationship between EPO and ROP. Further studies specifically designed should be performed. New ongoing studies on the neuroprotective role of EPO should consider this objective. In the mean time the use of EPO in the neonatal period should be cautious, mainly in very low birth weight infants.
Authors:
C Romagnoli; M G Tesfagabir; C Giannantonio; P Papacci
Related Documents :
760509 - Infantile atlantooccipital instability. the potential danger of extreme extension.
23879609 - Lactoferrin and the newborn: current perspectives.
6102679 - Excess morbidity and mortality associated with influenza in england and wales.
7275489 - A metapsychology put to the test of anxiety.
25355049 - Levels and determinants of low birth weight in infants delivered under the national hea...
8613749 - At least two mechanisms are involved in the death of retinal ganglion cells following t...
213549 - Peripheral median nerve damage secondary to brachial arterial blood gas sampling.
24534399 - Traumatic perforation of the lamina cribrosa during nasal intubation of a preterm infant.
3196049 - Faecal chymotrypsin concentrations in neonates with cystic fibrosis and healthy controls.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-7
Journal Detail:
Title:  Early human development     Volume:  -     ISSN:  1872-6232     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7708381     Medline TA:  Early Hum Dev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy and safety of antifungals in pediatric patients.
Next Document:  Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study.